NCE-407

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameNCE-407
Drug Alias NameSK-1393NCE-407
ClassificationSmall molecules
Mechanisms of ActionNuclear receptor ROR-gamma agonists
TargetsNuclear receptor ROR-gamma
Therapy Area/IndicationsPsoriasisPolyradiculoneuropathy, Chronic Inflammatory DemyelinatingMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSk Chemicals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSk Chemicals Co Ltd
Active IndicationsN/A
Inactive IndicationsPsoriasisPolyradiculoneuropathy, Chronic Inflammatory DemyelinatingMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A